Jean-louis L. Boulay
Basel, BS 4031, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Ancient IL-6-STAT5 signaling orchestrates inflammation in jawless vertebrates.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Quantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH-Wildtype Glioblastoma.
Journal: Journal of proteome research
Published: June 16, 2025
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.
Journal: Nature communications
Published: October 25, 2023
Proteome-based insights for IDH-mutant glioma classification.
Journal: Cell reports. Medicine
Published: January 18, 2023
Cytokine Receptor Diversity in the Lamprey Predicts the Minimal Essential Cytokine Networks of Vertebrates.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 26, 2022
Microglia-Centered Combinatorial Strategies Against Glioblastoma.
Journal: Frontiers in immunology
Published: June 12, 2020
Quantitative proteomics reveals reduction of endocytic machinery components in gliomas.
Journal: EBioMedicine
Published: April 15, 2019
Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1.
Journal: Brain pathology (Zurich, Switzerland)
Published: March 28, 2018
Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient Survival.
Journal: World neurosurgery
Published: January 24, 2018
Reverse phase protein arrays enable glioblastoma molecular subtyping.
Journal: Journal of neuro-oncology
Published: June 16, 2016
A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Journal: Cancer cell
Published: April 27, 2015
IDH mutation is associated with higher risk of malignant transformation in low-grade glioma.
Journal: Journal of neuro-oncology
Published: February 27, 2015
Last Updated: 09/26/2026